ISA Pharmaceuticals Appoints Ronald Loggers as Chief Executive Officer

07 Jul 2014

Leiden, The Netherlands, July 07, 2014 – ISA Pharmaceuticals B.V., a clinical-stage immunotherapy company focusing on rationally designed immunotherapeutics against cancer and persistent viral infections, today announced that the Company has hired Ronald Loggers, the former Chairman of ISA´s Supervisory Board, as Chief Executive Officer.

Previously, Ronald Loggers, M.Sc., MBA, was Managing Director of Multifund B.V., a family-owned investment firm and one of ISA’s major investors. Until June 2013, he served as the Chairman of the Supervisory Board and subsequently assumed the role of Acting CEO of ISA Pharmaceuticals.

From 1998 to 2005, Ronald Loggers worked for private equity firm HAL Investments.

Read more »